Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of the clinical stage of type 1 diabetes and to manage the underlying autoimmunity beginning at the time-at-onset and onwards. Initial phase I trials demonstrated that the admin...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2019
|
| Länkar: | https://doi.org/10.3389/fimmu.2019.00148 https://www.frontiersin.org/articles/10.3389/fimmu.2019.00148/pdf |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|